17 August 2020: Clinical Research
Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass
Xin-Ping Yu 1BCE , Ying Liu 2C , Jin-Wen Jiao 1D , Hong-Juan Yang 1B , Rui-Jing Wang 1D , Shuai Zhang 3ACF*DOI: 10.12659/MSM.924497
Med Sci Monit 2020; 26:e924497
Table 2 Comparison of qualitative MDCT features of SBOTs and SMOTs.
| MDCT feature | % of patients | P value | |
|---|---|---|---|
| SBOTs | SMOTs | ||
| Location | 0.083 | ||
| Unilateral | 45.8 (22/48) | 63.0 (34/54) | |
| Bilateral | 54.2 (26/48) | 37.0 (20/54) | |
| Tumor shape | 0.309 | ||
| Lobulated | 20.8 (10/48) | 29.6 (16/54) | |
| Round/oval | 79.2 (38/48) | 70.4 (38/54) | |
| Margins | 0.054 | ||
| Smooth | 83.3 (40/48) | 66.7 (36/54) | |
| Irregular | 16.7 (8/48) | 33.3 (18/54) | |
| Texture | 0.199 | ||
| Predominantly cystic | 87.5 (42/48) | 77.8 (42/54) | |
| Predominantly solid | 12.5 (6/48) | 22.2 (12/54) | |
| Papillary projections | 60.4 (29/48) | 37.4 (20/54) | 0.191 |
| Papillary projections with papillary surface | 12.5 (6/48) | 3.7 (2/54) | 0.143 |
| Discontinuous septa | 4.2 (2/48) | 14.8 (8/54) | 0.098 |
| Ascites | 35.4 (17/48) | 50.0 (27/54) | 0.138 |
| Vascular abnormalities | 16.7 (8/48) | 66.7 (36/54) | |
| All data are shown as % (n/N). SBOTs – serous borderline ovarian tumors; SMOTs – serous malignant ovarian tumors; MDCT – multidetector computed tomography. | |||